Intravenous thrombolysis guided by a telemedicine consultation system for acute ischaemic stroke patients in China: the protocol of a multicentre historically controlled study.
Intravenous thrombolysis guided by a telemedicine consultation system for acute ischaemic stroke patients in China: the protocol of a multicentre historically controlled study.
复制标题
DOI：
10.1136/bmjopen-2014-006704
复制
发表时间：
2015-05-15
期刊：
影响因子：
2.9
通讯作者：
Zhao G
中科院分区：
文献类型：
--
作者：
Yuan Z;Wang B;Li F;Wang J;Zhi J;Luo E;Liu Z;Zhao G
在中国，脑卒中患者使用组织型纤溶酶原激活剂或尿激酶静脉溶栓的比率极低。研究表明，远程卒中服务可能有助于提高静脉溶栓率，提高当地医院卒中护理质量。本研究也被称为急性脑卒中推进项目，旨在通过远程医疗会诊系统评估中国急性缺血性脑卒中患者静脉溶栓决策的有效性和安全性。这是一项多中心历史对照研究，计划在两组中每组招募300名参与者。远程中风网络由中国服务不足地区的一家中心医院和14家支线医院组成。在没有中心医院指导的情况下，以spoke医院的卒中照护质量作为历史对照。远程医疗会诊系统是一个交互式的、双向的、无线的、可在便携式设备上访问的视听系统。主要结局是卒中发生后4.5小时内接受静脉溶栓治疗的患者百分比。项目已通过西京医院机构评审委员会审核。研究结果将发表在科学期刊上，并提交给当地政府和相关机构。NCT02088346（2014年3月12日）。
The rate of intravenous thrombolysis with tissue-type plasminogen activator or urokinase for stroke patients is extremely low in China. It has been demonstrated that a telestroke service may help to increase the rate of intravenous thrombolysis and improve stroke care quality in local hospitals. The aim of this study, also called the Acute Stroke Advancing Program, is to evaluate the effectiveness and safety of decision-making concerning intravenous thrombolysis via a telemedicine consultation system for acute ischaemic stroke patients in China. This is a multicentre historically controlled study with a planned enrolment of 300 participants in each of two groups. The telestroke network consists of one hub hospital and 14 spoke hospitals in underserved regions of China. The usual stroke care quality in the spoke hospitals without guidance from the hub hospital will be used as the historical control. The telemedicine consultation system is an interactive, two-way, wireless, audiovisual system accessed on portable devices. The primary outcome is the percentage of patients treated with intravenous thrombolysis within 4.5 h of stroke onset. The project has been approved by the Institutional Review Board of Xijing Hospital. The results will be published in scientific journals and presented to local government and relevant institutes. NCT02088346 (12 March 2014).
登录
查看更多内容
影响因子：
48
作者：
Audebert, H
通讯作者：
Audebert, H
影响因子：
3.5
作者：
Dharmasaroja, Pornpatr A.;Muengtaweepongsa, Sombat;Kommarkg, Urai
通讯作者：
Kommarkg, Urai
影响因子：
158.5
作者：
Hacke, Werner;Kaste, Markku;Toni, Danilo
通讯作者：
Toni, Danilo
影响因子：
8.3
作者：
Jauch, Edward C.;Saver, Jeffrey L.;Yonas, Howard
通讯作者：
Yonas, Howard
影响因子：
8.3
作者：
VANSWIETEN, JC;KOUDSTAAL, PJ;VANGIJN, J
通讯作者：
VANGIJN, J